The treatment of non-small cell lung adenocarcinoma has become more successful due to targeted treatments based on the molecular profile of a patient’s particular tumor. The Lung Cancer Mutation Analysis panel is now available for clinical testing at the Spectrum Health Advanced Technology Laboratories (ATL).
Advanced Technology Laboratory, Cytogenetics, Molecular Diagnostics, Test Spotlight
Lung Cancer Mutation Analysis Panel provides targeted treatments for patients
